Advanced Therapies (ATMPs) & Next-Generation Biotherapeutics

services-star

Advanced therapies are transforming medicine while introducing entirely new development challenges. GSAP helps innovators navigate the complex regulatory, scientific, manufacturing, and clinical requirements unique to ATMPs, providing integrated support from early research through commercialization.

Body and Dna sketch

How We Support ATMP & Advanced Bio Developers

 

  • Regulatory Strategy & ATMP Pathways
    Defining tailored regulatory roadmaps, gap analyses, and expedited global pathways (including FDA RMAT/Breakthrough, EMA PRIME, and CAT scientific recommendations on classification) for cell and gene therapies, genome editing tools, tissue-engineered products, and exosome/secretome platforms.
  • Health Authority Interactions & Submissions
    Authoring and reviewing complex dossiers (IND, IMPD, BLA, MAA) and leading direct, proactive interactions with the FDA, EMA, Health Canada, IMOH, and national competent authorities.
  • Preclinical Strategy & Safety Evaluation
    Structuring translational programs, proof-of-concept (POC), toxicology, biodistribution, off-target effect, immunogenicity, and tumorigenicity studies, including protocol design and study oversight.
  • CMC, Vector & Process Development
    Strategic guidance for cell, viral/non-viral vector, tissue scaffold, and extracellular platforms (exosome/secretome) manufacturing process development, identity/purity/potency assays characterization, technology transfer, and CDMO selection/oversight.
  • Quality Systems & GxP Compliance
    Establishing and maintaining phase-appropriate Quality Management Systems (QMS), supplier qualification programs, EU/FDA GMP compliance, data integrity frameworks, and mock inspections.
  • Engineering, Validation & Facility Development
    Support for facility design, qualification, validation, process validation, cleaning validation, and GMP-compliant manufacturing infrastructure.
  • Clinical Strategy & CRO Execution
    End-to-end clinical development strategy, trial protocol design, full-service CRO oversight, clinical monitoring, and clinical study reporting (CSR) for complex advanced therapy trials.
  • Audits & Regulatory Inspection Readiness
    Executing internal, supplier, and CDMO qualification audits, gap assessments, and mock inspections to ensure audit readiness for regulatory approvals.